S
Stoke Therapeutics
Bedford, United States
Founded 2014 NASDAQ: STOK
About
Antisense oligonucleotides to upregulate protein expression
Company Details
- Type
- public
- Employees
- 200+
- Funding
- Public
Key Products
- TANGO Platform
- ASOs
Antisense oligonucleotides to upregulate protein expression